+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Malaria Diagnostics Market by Product Type and End User Global Opportunity Analysis and Industry Forecast, 2019-2026

  • PDF Icon

    Report

  • 171 Pages
  • March 2020
  • Region: Global
  • Allied Market Research
  • ID: 5031467
The global malaria diagnostics market accounted for $728,870 thousand in 2018 and is expected to reach $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026.





Malaria is an infectious ailment caused by the transmission of Plasmodium parasite. These parasites are transmitted through the bite of infected female Anopheles mosquito. Furthermore, these parasites invade cells of the liver, where they grow and multiply to further invade red blood cells. The mature form of these parasites lead to rupturing of blood cells to form merozoites. In addition, these merozoites further invade other red blood cells, which causes symptoms such as high fever, fatigue, and dizziness. Thus, malaria is highly fatal if left untreated for a long period of time. Tests and procedures which are employed in the identification of malaria are called as malaria diagnostics. Furthermore, there are different types of malaria diagnostics available in the market, which include rapid diagnostic tests, microscopy, and molecular diagnostic tests. In addition, these tests are performed in hospitals, clinics, and diagnostic centers.

The major factor that contributes to the growth of the malaria diagnostics market include rise in The prevalence of malaria in developing countries. Furthermore, surge in awareness initiatives by governments and an increase in research for new malaria diagnostics are the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is a major factor that restricts the market growth. Conversely, growth opportunities exhibited by emerging economies is expected to offer lucrative opportunities during the forecast period.

The malaria diagnostics market is studied on the basis of product type, end user, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into rapid diagnostic tests, microscopy, and molecular diagnostic tests. By end user, it is bifurcated into hospital, clinics, and diagnostic centers. Region wise, it is analyzed across North America (the U.S., and Canada, and Mexico), Europe (Germany, the UK, and rest of Europe), Asia-Pacific (China, India, and rest of Asia-Pacific), and LAMEA (Africa and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global malaria diagnostics market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Drug Class
  • Rapid Diagnostic Tests
  • Microscopy
  • Molecular Diagnostic Tests

By End User
  • Hospital
  • Clinics
  • Diagnostic Centers

By Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Africa
  • Rest of LAMEA

List of key players profiled in the report:
  • Abbott Laboratories
  • Access Bio. Inc.
  • Atlas Medical
  • Biomérieux SA
  • Bio-Rad Laboratories, Inc.
  • Meridian Bioscience Inc
  • Novartis AG
  • Olympus Corporation
  • Premier Medical Corporation Pvt Ltd.
  • Siemens AG

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • Nikon Corporation
  • Thermo Fisher Scientific

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Key forces shaping malaria diagnostics industry/market
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in The prevalence of malaria
3.4.1.2. Surge in healthcare expenditure worldwide
3.4.1.3. a rise in the adoption of malaria diagnostics across the globe
3.4.2. Restraint
3.4.2.1. Poor demand in under developed countries
3.4.3. Opportunity
3.4.3.1. High growth potential in developing economies
3.4.4. Impact Analyses
CHAPTER 4: MALARIA DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Rapid Diagnostic Tests
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.3. Microscopy
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
4.4. Molecular Diagnostic Tests
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis by country
CHAPTER 5: MALARIA DIAGNOSTICS MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Clinics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Diagnostic Centers
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
CHAPTER 6: MALARIA DIAGNOSTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market analysis, by country
6.2.2.1. U. S.
6.2.2.1.1. U. S. market size and forecast, by product type
6.2.2.1.2. U. S. market size and forecast, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by product type
6.2.2.2.2. Canada market size and forecast, by end user
6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market analysis, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by product type
6.3.2.1.2. Germany market size and forecast, by end user
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by product type
6.3.2.3.2. UK market size and forecast, by end user
6.3.2.4. Rest of Europe
6.3.2.4.1. Rest of Europe market size and forecast, by product type
6.3.2.4.2. Rest of Europe market size and forecast, by end user
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market analysis, by country
6.4.2.1. India
6.4.2.1.1. India market size and forecast, by product type
6.4.2.1.2. India market size and forecast, by end user
6.4.2.2. China
6.4.2.2.1. China market size and forecast, by product type
6.4.2.2.2. China market size and forecast, by end user
6.4.2.3. Rest of Asia-Pacific
6.4.2.3.1. Rest of Asia-Pacific market size and forecast, by product type
6.4.2.3.2. Rest of Asia-Pacific market size and forecast, by end user
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market analysis, by country
6.5.2.1. Arica
6.5.2.1.1. Arica market size and forecast, by product type
6.5.2.1.2. Arica market size and forecast, by end user
6.5.2.2. Rest of LAMEA
6.5.2.2.1. Rest of LAMEA market size and forecast, by product type
6.5.2.2.2. Rest of LAMEA market size and forecast, by end user
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Access Bio. Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.1. Key strategic moves and developments
7.3. Atlas Medical
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. BIOMÉRIEUX SA
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. Bio-Rad Laboratories, Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. Meridian Bioscience Inc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. NOVARTIS AG
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Olympus Corporation
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Premier Medical Corporation Pvt Ltd.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.10. SIEMENS
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

Executive Summary

According to this report titled, 'Malaria Diagnostics Market by Product Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026,' the global malaria diagnostics market size was valued at $728,870 thous and in 2018, and is expected to reach $1,085,106thous and by 2026, registering a CAGR of 5.1% from 2019 to 2026.

Malaria is a serious infectious disease, which can be lethal for the host if left untreated. Furthermore, it is transmitted through the bite of infected female Anopheles mosquito. The bite leads to spreading of Plasmodium parasites into the blood, which, in, turn spread to liver cells where they multiply at a fast rate to invade red blood cells. These parasites further grow and mature in red blood cells to form merozoites. These merozoites are responsible for rupturing of red blood cells to invade other red blood cells. This leads to fever, tiredness, vomiting, headaches, impaired consciousness, multiple convulsions, and abnormal bleeding. Hence, tests and procedures to identify the disease are necessary and are known as malaria diagnostics. There are different types of malaria diagnostics such as rapid diagnostic tests, microscopy, and molecular diagnostic tests.

The major factor that contributes to the growth of malaria diagnostics market include rise in The prevalence of malaria in developing countries. Furthermore, rise in awareness initiatives by governments and surge in research for new malaria diagnostics are the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is the major factor that restricts growth of the malaria diagnostics market. Conversely, growth opportunities exhibited by emerging economies is expected to offer lucrative opportunities during the forecast period.

The malaria diagnostics market is studied on the basis of product type, end user, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into rapid diagnostic tests, microscopy, and molecular diagnostic tests. By end user, it is bifurcated into hospital, clinics, and diagnostic centers. Region wise, it is analyzed across North America (the U.S., and Canada, and Mexico), Europe (Germany, the UK, and rest of Europe), Asia-Pacific (China, India, and rest of Asia-Pacific), and LAMEA (Africa and rest of LAMEA).

According to product type, rapid diagnostic tests acquired the major share of the malaria diagnostics market in 2018, owing to benefits associated with the use of RDTs in the diagnosis of malaria. For instance, RDTs are inexpensive, simple to operate and read, highly sensitive & specific, stable at high temperatures, and provide results in shorter period of time. Therefore, contribute to the growth of malaria diagnostic tests market. Furthermore, the molecular diagnostic tests segment is expected to grow at the fastest pace during the forecast period, owing to high specificity associated with the use of the test, which can lead to better treatment outcomes. In addition, rise in awareness among people regarding early diagnosis of malaria for better treatment supplements the growing demand for malaria diagnostic tests.

By end user, the clinics segment acquired the major share of the malaria diagnostics market, owing to surge in number of clinics worldwide. In addition, diagnostic centers are expected to exhibit the fastest growth rate during the forecast period due to surge in awareness related to early diagnosis of malaria infection for better treatment.

By region, LAMEA accounted for the major malaria diagnostics market share in 2018, and is expected to continue this trend, owing to rapid surge in The prevalence of malaria in the region. Moreover, widespread of the malaria vector, Anopheles gambiae, which is difficult to control, in the region is another major factor that leads to surge in cases of malaria. Furthermore, majority of malarial infections in the region are caused by the most lethal type of malarial parasite called as Plasmodium falciparum. Therefore, there is a need for early diagnosis of malaria infection in this region, which boosts the growth of the market. In addition, malaria infection is endemic to some parts of Africa, which leads to the growth of the market in the region. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period, attributed to the increase in awareness regarding the use of malaria diagnostics for early diagnosis of the infection for better treatment. The constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and Malaysia, as the constant development leads to surge in awareness related to the use of malaria diagnostics .

According to Onkar Sumant, Manager, Healthcare, “the demand formalaria diagnostics is on the rise, owing to surge in malaria across the globe. Furthermore, rise in awareness initiatives by governments is another major factor that contributes to the growth of this market.”

KEY FINDINGS OF THE STUDY
  • Rapid diagnostic tests segment occupied approximately half the share of the global malaria diagnostics market in 2018.
  • The molecular diagnostic tests segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • The hospitals segment accounted for one-thirds share of the market in 2018.
  • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

Companies Mentioned

  • Abbott Laboratories
  • Access Bio. Inc.
  • Atlas Medical
  • Biomérieux SA
  • Bio-Rad Laboratories Inc.
  • Meridian Bioscience Inc
  • Novartis AG
  • Olympus Corporation
  • Premier Medical Corporation Pvt Ltd.
  • Siemens AG

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...